DB17768Investigational
EF-022 is a modified version of vitamin D binding protein macrophage activator, with potential antineoplastic and anti-angiogenic activities.
- Mechanism
- Curator reviewed
Pharmacologically active on Vitamin D-binding protein
- Also known as
- Modified vitamin D binding protein · Modified Vitamin D Binding Protein Macrophage Activator
- Code names
- EF-022
Resolves to
Targets
What you can answer from here — as of July 08, 2026
Which drugs share a target with EF-022, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account